Headlines about Transcat (NASDAQ:TRNS) have trended somewhat positive recently, Accern Sentiment reports. The research firm identifies negative and positive media coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Transcat earned a news sentiment score of 0.13 on Accern’s scale. Accern also gave media headlines about the scientific and technical instruments company an impact score of 46.7029698293938 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
These are some of the news stories that may have impacted Accern’s analysis:
- Critical Contrast: Transcat (TRNS) & Its Rivals (americanbankingnews.com)
- Contrasting Transcat (TRNS) and Its Rivals (americanbankingnews.com)
- Critical Contrast: Methode Electronics (MEI) vs. Transcat (TRNS) (americanbankingnews.com)
- Head to Head Analysis: Transcat (TRNS) vs. Its Rivals (americanbankingnews.com)
- Transcat (TRNS) & Its Competitors Financial Survey (americanbankingnews.com)
Shares of Transcat (NASDAQ TRNS) opened at $15.72 on Tuesday. The company has a market cap of $111.94, a PE ratio of 23.12, a P/E/G ratio of 2.96 and a beta of 0.40. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.38 and a current ratio of 1.98. Transcat has a twelve month low of $11.02 and a twelve month high of $16.49.
Several brokerages recently commented on TRNS. Zacks Investment Research downgraded shares of Transcat from a “buy” rating to a “hold” rating in a report on Saturday. Roth Capital began coverage on shares of Transcat in a report on Friday. They set a “buy” rating and a $20.00 target price for the company. Finally, Singular Research lifted their target price on shares of Transcat from $15.30 to $20.00 and gave the stock a “buy” rating in a report on Monday, February 5th.
In other Transcat news, Director John T. Smith sold 2,000 shares of the business’s stock in a transaction dated Thursday, February 1st. The shares were sold at an average price of $15.70, for a total value of $31,400.00. Following the completion of the sale, the director now owns 33,100 shares of the company’s stock, valued at approximately $519,670. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 8.80% of the company’s stock.
TRADEMARK VIOLATION NOTICE: This news story was reported by Markets Daily and is the property of of Markets Daily. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://www.themarketsdaily.com/2018/02/13/transcat-trns-earning-somewhat-favorable-news-coverage-report-finds.html.
Transcat Company Profile
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.